Eight
The canSCREEN® platform, a purpose-built registry software, plays a crucial role in the cost-effective support of low to middle income countries in the realm of cancer prevention and early detection. Primarily in the Indo-Pacific region, these nations often grapple with limited healthcare resources, making efficient and impactful interventions paramount. canSCREEN® addresses these challenges by providing critical data recording, analysis and functionality to effectively manage patient follow-up and treatment in these regions.
The canSCREEN® platform has supported over 120,000 cervical screenings to date, and almost 10,000 treatment procedures, preventing many cancers from developing and ensuring proper care is provided where possible.
Cervical cancer is a significant public health concern in the Indo-Pacific, with some of the highest mortality rates globally. Traditional screening methods can be resource-intensive, but canSCREEN® facilitates the implementation of more cost-effective strategies such as self-collected HPV screening combined with immediate, point-of-care treatment. Studies in countries such as Papua New Guinea have demonstrated that this “screen-and-treat” approach, supported by canSCREEN®, is significantly more effective and economical than conventional approaches, leading to substantial reductions in cases and deaths.
canSCREEN®’s live performance dashboard shows how many women have been screened over time, the percentage of test results that were positive, unsatisfactory or negative, and several other performance indicators.
The platform’s core strength lies in its ability to manage comprehensive screening records, align with program policies, and provide real-time operational data which is crucial for effective program evaluation and continuous quality improvement. Its cloud-based architecture and mobile offline capabilities make it suitable for remote regions with limited connectivity, ensuring wider reach and accessibility for vulnerable populations. This digital health solution helps countries collect and utilise vital data to inform policy, allocate resources efficiently, and monitor the effectiveness of their cancer prevention services.
The global expansion of canSCREEN®, particularly across the Pacific, is a testament to its efficacy. It has been successfully implemented in Papua New Guinea, Vanuatu, the Cook Islands, Fiji, Malaysia, India, New Zealand, Timor-Leste, Kenya, Micronesia and Samoa with ongoing initiatives in Tuvalu, Nehru (Nauru), Kiribati and the Solomon Islands. These efforts are bolstered by collaboration with international partners and funding from donors such as the Australian Department of Foreign Affairs and Trade and philanthropic bodies including the Minderoo Foundation and the Swire Group. By enabling early diagnosis and streamlined patient pathways, canSCREEN® not only enhances health outcomes but also minimises the financial burden on fragile healthcare systems, demonstrating a sustainable and impactful approach to cancer control in the Pacific.
